Convergence, Divergence and Hybridity: A Regulatory Governance Perspective on Health Technology Assessment in England and Germany
- Publication Type:
- Journal Article
- Citation:
- Global Policy, 2017, 8 pp. 69 - 75
- Issue Date:
- 2017-03-01
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| Wright_et_al-2017-Global_Policy.pdf | Published Version | 307.61 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
© 2017 University of Durham and John Wiley & Sons, Ltd Countries adopt different methods and processes to evaluate the benefits and costs of health technologies. It is important to identify and analyse the factors that influence the uptake and use of these methods and processes across countries. In this article, we introduce a regulatory governance approach to the analysis of convergence, divergence and hybridity in Health Technology Assessment (HTA) methods, discussing and critically analysing national processes for HTA in two major EU member states: England and Germany. We argue that any reasonably sophisticated account of national approaches to HTA must recognise that globalisation and the emergence of advanced industrial society involves the potential for widely varying processes, methods and evidential requirements. We suggest that this potential also confronts health policy analysts with the challenge of constructing analytical frameworks capable of identifying the diverse institutional, domestic and other factors that shape national approaches to HTA.
Please use this identifier to cite or link to this item: